Dancann Pharma A/S filed its Annual on May 12, 2023 for the period ending Dec 31, 2022. In this report its auditor, Deloitte & Touche LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.07 DKK | -4.89% | -12.06% | +133.33% |
Mar. 29 | Dancann Pharma Plans Up to DKK19 Million Rights Issue | MT |
Feb. 28 | DanCann Pharma Notes Cannabis Legalization in Germany as Shares Surge | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+133.33% | 1.68M | |
+5.05% | 109B | |
+10.86% | 105B | |
-0.38% | 22.25B | |
-11.76% | 22.09B | |
-7.66% | 18.68B | |
-36.52% | 17.58B | |
-9.66% | 16.85B | |
+4.13% | 13.76B | |
+34.81% | 12.46B |
- Stock Market
- Equities
- DANCAN Stock
- News Dancann Pharma A/S
- Dancann Pharma A/S Auditor Raises 'Going Concern' Doubt